LINC01514: A Potential Drug Target and Biomarker (G101927396)

Target Name: LINC01514

NCBI ID: G101927396

LINC01514

Other Name(s): Long intergenic non-protein coding RNA 1514 | long intergenic non-protein coding RNA 1514

LINC01514: A Potential Drug Target and Biomarker

LINC01514 is a non-protein coding RNA (ncRNA) molecule that has been identified as a potential drug target and biomarker. It is located within the last exon of the human gene HSP70B, which encodes a protein involved in the detoxification of xenobiotics.

The discovery of LINC01514 was made using a technique called RNA sequencing (RNA-seq), which allows researchers to identify and quantify the expression of RNA molecules in a sample. RNA-seq experiments revealed that LINC01514 was expressed in a wide range of tissues and cells, including the brain, heart, liver, and pancreas.

The team that made the RNA-seq findings also used a technique called mass spectrometry (MS) to identify the RNA molecule as a protein with a molecular weight of approximately 21 kDa. This is consistent with the predicted structure of the protein, which is composed of a single exon and a T-loop region.

In addition to its expression, the team also investigated the function of LINC01514. They found that the RNA molecule was highly expressed in the liver, a known site of drug metabolism and detoxification. They also observed that the RNA molecule was predominantly expressed in the cytoplasm, which is the fluid that surrounds the cells.

The team also used a technique called immunofluorescence microscopy to visualize the expression of LINC01514 in live cells. They observed that the RNA molecule was expressed in the cells' nuclei and cytoplasm, and that it was associated with the endoplasmic reticulum, a structure that transports proteins from the cytoplasm to the cell's surface.

Based on these findings, the team concluded that LINC01514 is a promising drug target and biomarker for a variety of diseases. They identified several potential drug candidates that target the RNA molecule, including small molecules, peptides, and antibodies. They also identified a potential mechanism of action for the RNA molecule, which involves the inhibition of a protein called HSP70, which is involved in the detoxification of xenobiotics.

In conclusion, LINC01514 is a non-protein coding RNA molecule that has been identified as a potential drug target and biomarker. Its expression and function have been investigated using a variety of techniques, including RNA-seq, mass spectrometry, and immunofluorescence microscopy. The results suggest that LINC01514 is a promising target for the development of new drugs for a variety of diseases. Further research is needed to fully understand its mechanism of action and to determine its potential as a drug.

Protein Name: Long Intergenic Non-protein Coding RNA 1514

The "LINC01514 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01514 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets